Status:
COMPLETED
Duration of Antibiotic Treatment of Erythema Migrans
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
Erythema Chronicum Migrans
Eligibility:
All Genders
15+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare the efficacy of 15-day versus 10-day doxycycline treatment in patients with erythema migrans.
Eligibility Criteria
Inclusion
- solitary erythema migrans in patients \> 15 years
Exclusion
- a history of Lyme borreliosis in the past
- pregnancy or lactation
- immunocompromised status
- serious adverse event to doxycycline
- taking antibiotic with antiborrelial activity within 10 days
- multiple erythema migrans or extracutaneous manifestations of Lyme borreliosis
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
306 Patients enrolled
Trial Details
Trial ID
NCT00910715
Start Date
June 1 2009
End Date
November 1 2010
Last Update
June 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMC Ljubljana, Department of Infectious Diseases
Ljubljana, Slovenia, 1525